Search Results for "Menopause"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Menopause. Results 41 to 48 of 48 total matches.
Drugs for Overactive Bladder
The Medical Letter on Drugs and Therapeutics • Mar 20, 2023 (Issue 1672)
incontinence and vaginal
atrophy due to genitourinary syndrome of menopause.
In one small open-label trial ...
In overactive bladder, involuntary bladder contractions
due to detrusor overactivity result in urinary
urgency, frequency, nocturia, and incontinence.
The prevalence of the disorder increases with age.
Nonpharmacologic treatment, including bladder
training, urge suppression, pelvic floor muscle
exercises, constipation management, modification of
fluid intake, and avoidance of dietary irritants such as
alcohol and caffeine, should be tried first.
Med Lett Drugs Ther. 2023 Mar 20;65(1672):41-5 doi:10.58347/tml.2023.1672a | Show Introduction Hide Introduction
Drugs for Ovulation Induction
The Medical Letter on Drugs and Therapeutics • Oct 31, 2011 (Issue 1376)
and
Bravelle contain human menopausal gonadotropins.
Follitropin alfa (Gonal-f) and follitropin beta ...
Infertility occurs in about 15% of couples. About one-third
of cases are due to problems with ovulation or other
female factors, another third are due to a male infertility
factor, and the remaining third are unexplained. In older
women, unexplained infertility is probably caused by
diminished quality and quantity of oocytes. The first
approach to treatment of female-factor infertility generally
is the use of drugs that stimulate oocyte production.
New Drugs for Osteoporosis
The Medical Letter on Drugs and Therapeutics • Jan 05, 1996 (Issue 965)
. It appears to be most effective when started in the first few years after menopause, but has also showed some ...
Two new drugs alendronate (Fosamax - Merck) and salmon calcitonin nasalspray (Miacalcin - Sandoz) are now available in the USA for treatment of postmenopausalosteoporosis. A third drug for treatment of osteoporosis, a slow-release fluoridepreparation (Slow Fluoride -Mission Pharmacal), has been recommended for approvalby an advisory committee of the US Food and Drug Administration (FDA). Various formulationsof fluoride have been available in Europe for this indication for many years.
Vitamin Supplements
The Medical Letter on Drugs and Therapeutics • Jul 18, 2005 (Issue 1213)
vitamin A supplements during pregnancy or after menopause. No one should take highdose beta carotene ...
Many patients ask their physicians whether they should take vitamins. Since the last Medical Letter article on this subject, more data have become available on the benefits and risks of taking vitamin supplements.
Drugs for Assisted Reproduction
Treatment Guidelines from The Medical Letter • Oct 01, 2003 (Issue 14)
from
the urine of postmenopausal women. Bravelle also contains human menopausal gonadotropins, but is primarily ...
Infertility occurs in about 15% of couples. About one third of infertility is due to problems with ovulation or an anatomic abnormality of the fallopian tube or peritoneum, such as scarring, adhesions or endometriosis. Another third is due to a male infertility factor, most commonly insufficient sperm production or abnormal motility or morphology. The remaining third is unexplained. In older women unexplained infertility is probably caused by diminished quality and quantity of oocytes, decreased implantation and spontaneous pregnancy wastage.
Drugs for Hypothyroidism
The Medical Letter on Drugs and Therapeutics • Feb 20, 2023 (Issue 1670)
or become pregnant or become menopausal.
Patients requiring higher-than-usual doses of LT4
to normalize ...
Primary hypothyroidism is usually the result of
Hashimoto's (autoimmune) thyroiditis, thyroidectomy,
or radioactive iodine therapy. Treatment of
hypothyroidism with replacement doses of thyroid
hormone is usually lifelong. Levothyroxine (LT4;
synthetic thyroxine; Synthroid, and others) is the drug
of choice.1
Med Lett Drugs Ther. 2023 Feb 20;65(1670):25-9 doi:10.58347/tml.2023.1670a | Show Introduction Hide Introduction
Choice of Contraceptives
The Medical Letter on Drugs and Therapeutics • May 15, 2023 (Issue 1676)
. Menopause Rev 2018; 17:1.
10. C Shufelt and A LeVee. Hormonal contraception in
women with hypertension ...
Intrauterine devices (IUDs) and the etonogestrel
implant are the most effective reversible contraceptive
methods available. Hormonal oral contraceptives,
patches, rings, and injectables are also effective in
preventing pregnancy. When used alone, barrier and
behavioral methods generally have higher failure
rates than other methods (see Table 1). Selection of
a contraceptive method is usually based on patient-specific factors and personal preference
Med Lett Drugs Ther. 2023 May 15;65(1676):73-80 doi:10.58347/tml.2023.1676a | Show Introduction Hide Introduction
Drugs for Thyroid Disorders
Treatment Guidelines from The Medical Letter • Aug 01, 2009 (Issue 84)
- menopausal women started be adjusted if estrogen is
tions, leading to decreased on estrogen replacement ...
Primary hypothyroidism is usually the result of Hashimoto's thyroiditis, thyroidectomy for hyperthyroidism, goiter or cancer, or radioactive iodine therapy for hyperthyroidism.